Company intelligence / Profile preview
Garwychem Healthcare
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
Overview
Garwychem Healthcare is an Indian pharmaceutical company established in 2023 and based in Panchkula, Haryana. The company operates as a PCD (Propaganda Cum Distribution) franchise and third-party manufacturer, wholesaler, and distributor of a diverse range of pharmaceutical formulations. Its product portfolio includes tablets, capsules, softgel capsules, syrups, injectables, ointments, and beta-lactams covering therapeutic areas such as orthopedics, gynecology, pediatrics, gastroenterology, neurology, and nutrition. Garwychem Healthcare focuses on providing high-quality, affordable, and effective medicines to enhance the healthcare ecosystem across India.
- Modalities
- Small molecule
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on Garwychem Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Garwychem Healthcare.